Back to Search
Start Over
The Efficacy and Safety of Tislelizumab as Adjuvant Treatment for Advanced or Metastatic Bladder Cancer in People Living With HIV: A Retrospective Multi-Center Study.
- Source :
- Cancer Control: Journal of the Moffitt Cancer Center; 4/28/2023, p1-10, 10p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 10732748
- Database :
- Complementary Index
- Journal :
- Cancer Control: Journal of the Moffitt Cancer Center
- Publication Type :
- Academic Journal
- Accession number :
- 163407954
- Full Text :
- https://doi.org/10.1177/10732748231173475